The erythroid differentiation of K562 cells depends on the nuclear translocation of Akt Missiroli, Silvia; Etro, Daniela; Neri, Luca Maria; Capitani, Silvano details >>	il sedicesimo - Firenze, ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY pp: 183-183, Anno: 2006

Nucleolin: a nuclear Akt substrate Etro, Daniela; Missiroli, Silvia; Neri, Luca Maria; Capitani, Silvano details >>	il sedicesimo - Firenze, Italian Journal of Anatomy and Embryology pp: 90-90, Anno: 2006

Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent AKT reactivation. Simioni, C; Cani, A; Martelli, Am; Zauli, G; Capitani, S; Neri, Lm details >>	AMER ASSOC CANCER RESEARCH, MOLECULAR CANCER THERAPEUTICS Vol. 14 Supplement: S, No. 1, pp: 1-1, Anno: 2015

Therapeutic potential of the novel mTOR inhibitor Torin-2 to overcome AKT reactivation in B-precursor acute lymphoblastic leukemia (B-pre ALL). Cani, A.; Simioni, C.; Martelli, A. M.; Zauli, G.; Capitani, S.; Neri, L. M. details >>	AMER ASSOC CANCER RESEARCH, -- Vol. 21 Supplement: 17, No. 1, pp: 1-1, Anno: 2015

The novel Akt inhibitor MK-2206, is cytotoxic in T-cell acute lymphoblastic leukemia: Therapeutic implications Simioni, C.; Cani, A.; Bressanin, D.; Evangelisti, C.; Chiarini, F.; Capitani, S.; Neri, L. M.; Martelli, A. M. details >>	AMER ASSOC CANCER RESEARCH, -- Vol. 72, No. 1, pp: 1-1, Anno: 2012

The mTOR inhibitor, RAD001, displays higher cytotoxicity in leukemias with hyperactivated PI3K/AKT/mTOR pathway Cani, A.; Simioni, C.; Capitani, S.; Martelli, A. M.; Neri, L. M. details >>	AMER ASSOC CANCER RESEARCH, -- Vol. 72 Supplement: 8, No. 1, pp: 1-1, Anno: 2012